Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
ELTX
$1.56
-4.29%
ELTX
· Elicio Therapeutics, Inc.
$1.56
-0.07 (-4.29%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”View the 10-Q filed Nov 5, 2026
Market Cap
$44.16M
Shares
28.31M
Volume · Nov 12
232.82K
Avg daily vol (3M)
320.42K
All webcasts
Earnings call · FY2026 Q1
Elicio Therapeutics, Inc. (ELTX) Q1 2026 Earnings Call
Diluted EPS
-$0.65
Net income
-$11.82M
Research coverage
4 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
16 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed May 11, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 11, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Jun 15, 2026 · complete as-filed document